Anika Therapeutics, Inc. (ANIK) NASDAQ

16.19

-0.02(-0.12%)

Updated at January 03 04:00PM

Currency In USD

Valuation

Market Cap332.1M
Enterprise Value288.27M
P/E Ratio-2.45
PEG Ratio0.08
Price/Sales Ratio1.44
Price/Book Ratio1.33
Enterprise/Revenue1.23
Enterprise/EBITDA-8.76

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-0.59
Operating Margin-0.21

Management Effectiveness

Return On Assets-0.42
Return On Equity-0.48

Income Statement

Revenue166.66M
Revenue/Share11.12
Gross Profit103.09M
EBITDA-11.23M
Net Income-82.67M
Diluted EPS-5.64

Balance Sheet

Total Cash62.37M
Total Cash/Share4.22
Total Debt27.53M
Total Debt/Equity0
Current Ratio5.34
Book Value Per Share12.18

Price History

52-Week Change-26.64
52-Week High29.12
52-Week Low15.83
Moving Average 50 Days18.07
Moving Average 200 Days23.87

Statistics

Average Volume97,229
Shares Outstanding14.65M
% Held by Institutions88.66

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A